CalPERS Commends GlaxoSmithKline's Move to Cut Price of AIDS Drugs.Business Editors/High-Tech Writers SACRAMENTO Sacramento, city, United States Sacramento (săkrəmĕn`tō), city (1990 pop. 369,365), state capital and seat of Sacramento co., central Calif. , Calif.--(BUSINESS WIRE)--April 28, 2003 Sean Harrigan, President of the California California (kăl'ĭfôr`nyə), most populous state in the United States, located in the Far West; bordered by Oregon (N), Nevada and, across the Colorado River, Arizona (E), Mexico (S), and the Pacific Ocean (W). Public Employees' Retirement System's (CalPERS) Board of Administration issued the following statement today about news that GlaxoSmithKline is cutting the price of its combination AIDS drug Combivir: "Glaxo should be commended for this move. It is a significant step forward for the company. We asked the company to examine the price of their AIDS therapy AIDS therapy HIV treatment may be: preventive-eg to prevent in utero infection of HIV-positive mothers; prophylactic-eg to prevent opportunistic infections when CD4 levels fall below certain level; based on efficacy. See AIDS fraud, AIDS quackery, AIDS vaccine. drugs and offer the lowest possible price without long-term Long-term Three or more years. In the context of accounting, more than 1 year. long-term 1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term. harm to the company. Glaxo has answered with good news that will help advance the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. work in the world's poorest countries while considering the financial health of its shareholders." "We recognize that Glaxo has an established and effective humanitarian programs. We urge them to continue to work with the AIDS community to further their efforts, and we look forward to a continued dialogue with the company about their work in this area." |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion